Kristin Siyahian

---

Authored Items

Immunotherapy and the Moon Shots Program:

An Interview with Dr James Allison of MD Anderson Cancer Center

November 2014, Part 4 - Interview with the Innovators

Harnessing the power of the immune system to combat cancer is not a new idea; however, the new generation of immunotherapeutic agents have captured the imagination of those in the oncology community and sparked a renewed interest in the potential capabilities of an empowered immune system. As a result, immunotherapy [ Read More ]

PMO and the PMC – A Collaboration to Advance Precision Medicine

June 2014, Vol 3, No 4 - The Last Word

Introducing Dr Edward Abrahams, President of PMC, as the Author of The Last Word Since the inception of Personalized Medicine in Oncology (PMO), we have offered the department The Last Word in which we sum up thoughts on various overriding themes in the world of personalized medicine. In this thought-provoking [ Read More ]

A Breakthrough Treatment for ALL and CLL: The New Biologic Agent, CTL019

An Interview With David L. Porter, MD, of the University of Pennsylvania

May 2014, Vol 3, No 3 - Interview with the Innovators

David L. Porter, MD, is Jodi Fisher Horowitz Professor in Leukemia Care Excellence in the Perelman School of Medicine at the University of Pennsylvania; and Director, Blood and Marrow Transplantation at the Abramson Cancer Center.The number of patients was small and the therapy still investigational, but the results of research [ Read More ]

Personalizing Therapeutics for Melanoma in the 21st Century

June 2012, Vol 1, No 2 - Conference Correspondent

Advocating for biomarker-driven “smart” trials, making the case for patient selection for specific drugs, and the concept of rational combinations as potential targeted therapies in order to improve the efficacy of clinical trials were topics of an insightful presentation delivered by Dr Aleksandar Sekulic on behalf of Dr Pat LoRusso [ Read More ]